Home Differentiated Therapeutics

Differentiated Therapeutics

In operation
Seed Round Financing
TPD Therapy Developer
Basic
Enterprise Profile

Basic Information

Differentiated Therapeutics (dx/tx) is a protein degradation company dedicated to discovering and developing transformative drugs to change patients' lives. Differentiated Therapeutics focuses on computational prediction and optimization of targeted protein degraders (TPD). Differentiated Therapeutics has built the first end-to-end discovery engine for targeted protein degradation (TPD), which drives the discovery and optimization of novel protein degraders aimed at eliminating genetically defined disease drivers.
Differentiated Therapeutics
Boston,Massachusetts,United States of America
less than 15 people
January 01, 2021
info@dxtherapeutics.com

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Chemical Pharmaceutical Preparations
Technology
Targeted Technology Protein Technology
Application Scenarios
Chemical Drug Innovative Drugs